AllerGene AI Therapeutics is pioneering the first in vivo mRNA-LNP CAR-T platform designed to eliminate disease-driving mast cells, safely resetting the immune system without permanent alteration. Mast cells are central drivers of mast-cell-driven diseases such as mastocytosis and chronic urticaria... Read more
This company has no teams yet
This company has no offices yet